Printer Friendly

ANGEION CORPORATION SEEKS NEW PRESIDENT

 MINNEAPOLIS, May 11 /PRNewswire/ -- Angeion Corporation (NASDAQ: ANGN) announced today it had begun a search for a new president to direct the transition of the company from a research and development company into an operating company. Angeion is looking for an individual with proven skills and management experience in a growing medical products company. The new president will report to and work closely with Angeion's board of directors and Chairman Wendell King to move the company's products forward through regulatory approval and into manufacturing and product launch. King will remain chairman of Angeion's board of directors.
 "This is an important move for Angeion's next phase of growth and will help to ensure the company's continued success," said King. "This addition will strengthen our management team and allow me to focus more on the long range, strategic positioning of the company."
 Minneapolis-based Angeion is developing three products for treating various types of arrhythmias, or irregular heartbeats. An automatic implantable defibrillator and a laser catheter ablation system are being developed to treat patients with ventricular tachycardia, a life- threatening rapid heartbeat. A third device, an external temporary pacemaker, is being developed to treat hospital patients whose heart is beating too slowly. The devices are in various stages of development.
 -0- 5/11/93
 /CONTACT: Brenda Roth of Angeion, 612-550-9388/
 (ANGN)


CO: Angeion Corporation ST: Minnesota IN: MTC SU: PER

KH -- MN006 -- 7009 05/11/93 11:33 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 11, 1993
Words:236
Previous Article:INTERNATIONAL ALUMINUM CORP. ANNOUNCES RESULTS
Next Article:DOTRONIX ANNOUNCES THIRD QUARTER RESULTS
Topics:


Related Articles
ANGEION NAMES EMPI FOUNDER & CEO TO BOARD
ANGEION RELEASES FIFTH PRODUCT FAMILY
ANGEION REPORTS THIRD QUARTER RESULTS; SECURES INITIAL BRIDGE LOAN
ANGEION REPORTS FIRST QUARTER RESULTS
ANGEION VICE PRESIDENT RESIGNS
ANGEION RECEIVES FDA AUTHORIZATION TO CONDUCT CLINICAL TRIALS
Angeion Names New Members to Board of Directors.
Angeion Corporation CEO to Retire at Fiscal Year End.
Angeion Corporation Appoints New CEO.
Angeion Receives Favorable Ruling in Insurance Coverage Case.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters